NCT07293910 2026-02-13
Vonoprazan vs Proton Pump Inhibitor With Vitamin D or Probiotics Based Triple Therapy for Eradication of Helicobacter Pylori Infection
Tanta University
Phase 2 Recruiting
Clinical Trials
23 trialsNCT00396279 2022-11-08
Safety and Efficacy Study of Denosumab in Patients With Recurrent or Unresectable Giant Cell Tumor of Bone
Amgen
Phase 2 Completed
NCT01968590 2022-05-25
VitDBoneNF1
University of Utah
Phase 2 Terminated
NCT01516216 2022-04-26
Study of Vitamin D in Untreated Metastatic Colorectal Cancer
Dana-Farber Cancer Institute
Phase 2 Completed
NCT03520231 2021-11-23
Study Comparing Denosumab With Standard Treatment in Urothelial Cancer Patients With Bone Metastases
University Health Network, Toronto
Phase 2 Completed
NCT03192059 2021-09-08
PRIMMO
University Hospital, Ghent
Phase 2 Completed
NCT02186015 2021-05-14
SAFE-D
Loyola University
Phase 2 Completed
NCT04166253 2021-02-03
VDDOXO
Damanhour University
Phase 2 Completed
NCT01317940 2020-07-08
Nutrition and Body Composition in Acute Lymphoblastic Leukemia
Children's Hospital Los Angeles
Phase 2 Completed
NCT02341495 2020-02-27
EXJADE
Loyola University
Phase 2 Terminated
NCT00582582 2019-12-13
Study of Docetaxel With Doxercalciferol or Placebo for Advanced Prostate Cancer
University of Wisconsin, Madison
Phase 2 Terminated
NCT04091178 2019-09-16
OPTIVIT
Institut du Cancer de Montpellier - Val d'Aurelle
Phase 2 Completed
NCT02795572 2019-07-05
CIPN
AHS Cancer Control Alberta
Phase 2 Terminated
NCT01472445 2019-04-19
Vitamin D and Breast Cancer: Does Weight Make a Difference?
Stanford University
Phase 2 Terminated
NCT00499408 2018-11-21
Vitamin D and Soy Supplements in Treating Patients With Recurrent Prostate Cancer
Wake Forest University Health Sciences
Phase 2 Completed
NCT02656121 2018-11-16
PCOSD
Ain Shams University
Phase 2 Completed
NCT00867217 2018-02-09
VITAL
University of Kansas Medical Center
Phase 2 Completed
NCT00656019 2017-12-02
Development of Vitamin D as a Therapy for Breast Cancer - Phase 2
Stanford University
Phase 2 Completed
NCT01965522 2017-06-16
MELO-D
Juravinski Cancer Center
Phase 2 Completed
NCT00073073 2016-05-17
Exemestane and Celecoxib in Postmenopausal Women at High Risk for Breast Cancer
Georgetown University
Phase 2 Completed
NCT01948128 2016-02-03
OTT 12-06
Ottawa Hospital Research Institute
Phase 2 Completed
NCT01039181 2009-12-24
Calcitriol in Advanced Intrahepatic Cholangiocarcinoma
National Science and Technology Development Agency, Thailand
Phase 2 Unknown
NCT00172068 2009-12-23
MRD-1
Novartis
Phase 2 Terminated